BACKGROUND: The development of obesity has been suggested to involve plasminogen activator inhibitor-1 (PAI-1) and tissue inhibitor of proteinases-1 (TIMP-1). Plasma PAI-1 is elevated in obesity. A low-glycemic-index (LGI) diet may have a beneficial effect on obesity through a decrease in plasma PAI-1, but whether it affects plasma TIMP-1 in healthy humans has not been studied. OBJECTIVE: We investigated whether a 10-wk intake of an LGI or a high-glycemic-index (HGI), high-carbohydrate, low-fat, ad libitum diet is associated with decreases in plasma PAI-1 and TIMP-1 concentrations in overweight women. DESIGN:Forty-four overweight women [body mass index (BMI; in kg/m2): 27.5+/-0.23] were randomly assigned to consume an HGI or an LGI diet for 10 wk. A subgroup of 29 women was assigned to participate in an additional 4-h meal test on the last day of the 10-wk intervention. RESULTS:PAI-1 activity decreased after 10 wk of the LGI diet and was significantly different between groups. Changes in PAI-1 antigen followed the same trend, but no significant difference was observed between groups. No difference in plasma TIMP-1 concentrations was observed between groups. PAI-1 and TIMP-1 concentrations after the 4-h meal test were not significantly different between groups. CONCLUSION: An LGI diet reduces fasting plasma PAI-1 activity and therefore may be useful for diminishing the adverse cardiovascular effects of obesity. This trial was registered at clinicaltrials.gov as NCT00324090.
RCT Entities:
BACKGROUND: The development of obesity has been suggested to involve plasminogen activator inhibitor-1 (PAI-1) and tissue inhibitor of proteinases-1 (TIMP-1). Plasma PAI-1 is elevated in obesity. A low-glycemic-index (LGI) diet may have a beneficial effect on obesity through a decrease in plasma PAI-1, but whether it affects plasma TIMP-1 in healthy humans has not been studied. OBJECTIVE: We investigated whether a 10-wk intake of an LGI or a high-glycemic-index (HGI), high-carbohydrate, low-fat, ad libitum diet is associated with decreases in plasma PAI-1 and TIMP-1 concentrations in overweight women. DESIGN: Forty-four overweight women [body mass index (BMI; in kg/m2): 27.5+/-0.23] were randomly assigned to consume an HGI or an LGI diet for 10 wk. A subgroup of 29 women was assigned to participate in an additional 4-h meal test on the last day of the 10-wk intervention. RESULTS:PAI-1 activity decreased after 10 wk of the LGI diet and was significantly different between groups. Changes in PAI-1 antigen followed the same trend, but no significant difference was observed between groups. No difference in plasma TIMP-1 concentrations was observed between groups. PAI-1 and TIMP-1 concentrations after the 4-h meal test were not significantly different between groups. CONCLUSION: An LGI diet reduces fasting plasma PAI-1 activity and therefore may be useful for diminishing the adverse cardiovascular effects of obesity. This trial was registered at clinicaltrials.gov as NCT00324090.
Authors: Diego Botero; Cara B Ebbeling; Jeffrey B Blumberg; Judy D Ribaya-Mercado; Mark A Creager; Janis F Swain; Henry A Feldman; David S Ludwig Journal: Obesity (Silver Spring) Date: 2009-06-18 Impact factor: 5.002
Authors: Christine Clar; Lena Al-Khudairy; Emma Loveman; Sarah Am Kelly; Louise Hartley; Nadine Flowers; Roberta Germanò; Gary Frost; Karen Rees Journal: Cochrane Database Syst Rev Date: 2017-07-31
Authors: Freek G Bouwman; Baukje de Roos; Isabel Rubio-Aliaga; L Katie Crosley; Susan J Duthie; Claus Mayer; Graham Horgan; Abigael C Polley; Carolin Heim; Susan L M Coort; Chris T Evelo; Francis Mulholland; Ian T Johnson; Ruan M Elliott; Hannelore Daniel; Edwin C M Mariman Journal: BMC Med Genomics Date: 2011-03-25 Impact factor: 3.063
Authors: Laura Chiavaroli; Cyril W C Kendall; Catherine R Braunstein; Sonia Blanco Mejia; Lawrence A Leiter; David J A Jenkins; John L Sievenpiper Journal: BMJ Open Date: 2018-04-02 Impact factor: 2.692